KAYLA HESS: Open Payments
NPI 1902238439 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 6 payments from 5 companies in 2025. Trend: 2023 $570 · 2024 $533 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $123 |
| Organon LLC | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: Opzelura, VTAMA, Exparel, EUFLEXXA.
Industry payments across PA — which companies pay providers there.
